請參考07月06日聯合新聞網、LINE TODAY 、Yahoo 新聞、人間福報等報導本校新聞剪報。
主題：弘光科大教授以甲殼素研發「智能奈米水膠」榮登全球頂尖藥學類期刊
糖尿病足潰瘍引起的慢性傷口，是醫學上導致患者截肢的棘手難題。弘光科技大學食品科技系教授羅婉瑜帶領的「保健品暨新藥開發實驗室」，今年再度取得重大突破！成功利用保健食品原料「甲殼素」為載體，開發出糖尿病傷口專用的奈米級核酸藥物，研究成果獲刊登於生物醫學領域等級的頂尖國際期刊《International Journal of Nanomedicine》。
Please refer to the school’s news clippings reported on July 6 by United Daily News (UDN), LINE TODAY, Yahoo News, and The Merit Times.
Topic:Hungkuang University Professor Develops “Smart Nanohydrogel” Using Chitosan, Featured in World’s Top Pharmacy Journal
Diabetic foot ulcers (DFUs) and the resulting chronic wounds present a difficult challenge in medicine, often leading to patient amputations. The “Nutraceuticals and New Drug Development Laboratory,” led by Professor Lo Wan-Yu from the Department of Food Science and Technology at Hungkuang University, has achieved another major breakthrough this year!
The team successfully utilized “chitosan,” a common health food ingredient, as a carrier to develop a nanoscale nucleic acid drug specifically for diabetic wounds. This research achievement has been published in the International Journal of Nanomedicine, a top-tier international journal in the biomedical field.
媒體報導連結如下：
聯合新聞網 https://pse.is/9anfvk
LINE TODAY https://pse.is/9anh6l
yahoo新聞 https://pse.is/9anfxv
台灣好新聞 https://pse.is/9anfts
[life.tw] https://pse.is/9ang9d
臺灣人民報 https://pse.is/9angm7
PChome 新聞 https://pse.is/9angpy
Owlnews https://pse.is/9angw7
熱訊生活新聞網 https://pse.is/9anhth
善思新聞網 https://pse.is/9anjzw
